dalteparin has been researched along with Cancer of Muscle in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davutoglu, V | 1 |
Kervancioglu, S | 1 |
Sezen, Y | 1 |
Olsson, E | 1 |
Svartling, N | 1 |
Asko-Seljavaara, S | 1 |
Lassila, R | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Remote Ischemic Preconditioning in Head and Neck Cancer Reconstruction - A Randomized Controlled Trial[NCT02548377] | 60 participants (Actual) | Interventional | 2015-09-29 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for dalteparin and Cancer of Muscle
Article | Year |
---|---|
Activation of coagulation and fibrinolysis during reconstructive microsurgery in patients with cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Blood Coagulation; Bone Neoplasms; Dalteparin; | 2001 |
1 other study available for dalteparin and Cancer of Muscle
Article | Year |
---|---|
Large rectus muscle hematoma with intraperitoneal bleeding and fatal abdominal compartment syndrome complicating anticoagulant therapy.
Topics: Anticoagulants; Compartment Syndromes; Enoxaparin; Fatal Outcome; Female; Hematoma; Hemorrhage; Huma | 2005 |